Resource use from the oral semaglutide and liraglutide arms of PIONEER 4 was used to inform annual treatment costs, with 100% of patients receiving concomitant metformin in both arms and 26.0% and 25.7% receiving a concomitant SGLT-2 inhibitor in the oral semaglutide and liraglutide arms, respectively
A high uptake of glucose in tumor cells not only serves for energy production but also for protection from endogenous and exogenous reactive oxygen species because NADPH, a by-product of the oxidative pentose phosphate pathway, is used to regenerate glutathione, an important cellular antioxidant
By adhering to the prescribed dosage and adjusting as necessary under medical supervision, patients can enhance their treatment outcomes and improve their overall quality of life
Leveraging the University of California Health Data Warehouse enabled a realworld analysis of 6,871 patients with primary colon cancer and rigorous adjustment strategies to probe whether GLP1 RA exposure relates to fiveyear mortality. At the end of the study, researchers found that participants with colon cancer taking GLP-1 medications had a 15.5% mortality risk within 5 years, compared to 37.1% in participants not taking the drugs
